[go: up one dir, main page]

AU1751795A - Liposome compositions and methods for the treatment of atherosclerosis - Google Patents

Liposome compositions and methods for the treatment of atherosclerosis

Info

Publication number
AU1751795A
AU1751795A AU17517/95A AU1751795A AU1751795A AU 1751795 A AU1751795 A AU 1751795A AU 17517/95 A AU17517/95 A AU 17517/95A AU 1751795 A AU1751795 A AU 1751795A AU 1751795 A AU1751795 A AU 1751795A
Authority
AU
Australia
Prior art keywords
atherosclerosis
treatment
methods
liposome compositions
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17517/95A
Inventor
Michael J Hope
Wendi Rodrigueza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of AU1751795A publication Critical patent/AU1751795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
AU17517/95A 1994-03-04 1995-03-03 Liposome compositions and methods for the treatment of atherosclerosis Abandoned AU1751795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20641594A 1994-03-04 1994-03-04
US206415 1994-03-04
PCT/CA1995/000119 WO1995023592A1 (en) 1994-03-04 1995-03-03 Liposome compositions and methods for the treatment of atherosclerosis

Publications (1)

Publication Number Publication Date
AU1751795A true AU1751795A (en) 1995-09-18

Family

ID=22766270

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17517/95A Abandoned AU1751795A (en) 1994-03-04 1995-03-03 Liposome compositions and methods for the treatment of atherosclerosis

Country Status (2)

Country Link
AU (1) AU1751795A (en)
WO (1) WO1995023592A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312719B1 (en) 1994-03-04 2001-11-06 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
US6773719B2 (en) 1994-03-04 2004-08-10 Esperion Luv Development, Inc. Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
US5746223A (en) * 1996-10-11 1998-05-05 Williams; Kevin Jon Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis
EP0863748A4 (en) * 1995-10-11 1999-11-03 Kevin Jon William Liposomal compositions and methods of using them
FR2764507B1 (en) * 1997-06-11 2000-10-20 Lipogel Sarl PULVERULENT COMPOSITIONS OF SINGLEAMELLAR LIPOSOMES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS AS NUTRITIONAL SUPPLEMENTS AND AS NUTRITIONAL SUPPLEMENTS AND AS MEDICINAL PRODUCTS
RU2128991C1 (en) * 1998-06-23 1999-04-20 Общество с ограниченной ответственностью "ЭМУ-Темп" Biologically active emulsion preparation
EP1183011A4 (en) * 1999-05-14 2005-01-19 Esperion Luv Dev Inc Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
US20010028895A1 (en) * 2000-02-04 2001-10-11 Bisgaier Charles L. Methods of treating alzheimer's disease
TWI281407B (en) 2000-09-18 2007-05-21 Vasogen Ireland Ltd Apoptosis-mimicking synthetic entities and use thereof in medical treatment
CA2319928A1 (en) * 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments
US6838452B2 (en) 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
AU1846102A (en) * 2000-11-24 2002-06-03 Cardimmune Ltd Methods employing and compositions containing defined oxidized phospholipids forprevention and treatment of atherosclerosis
WO2003026492A2 (en) 2001-09-28 2003-04-03 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug
CA2368656A1 (en) * 2002-01-21 2003-07-21 Vasogen Ireland Limited Receptor-ligand pairing for anti-inflammatory response
NZ534142A (en) * 2002-01-21 2007-08-31 Vasogen Ireland Ltd Pharmaceutically acceptable phosphate-glycerol carrying bodies comprising phospatidylglycerol and/or phosphatidylcholine and/or phosphatidylglycerol
WO2005007169A2 (en) * 2003-07-21 2005-01-27 Vasogen Ireland Limited Liposomes containing phosphate glycerol groups for treating acute inflammatory condition
EP1918000A2 (en) 2003-11-05 2008-05-07 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
EP1732383A4 (en) 2004-04-06 2007-05-02 Cedars Sinai Medical Center PREVENTION AND TREATMENT OF VASCULAR DISEASES WITH VIRUS VECTORS ASSOCIATED WITH RECOMBINANT ADENOVIRUS CODING APOLIPOPROTEIN A-I AND APOLIPOPROTEIN A-I MILANO
JP4767948B2 (en) 2004-07-09 2011-09-07 ヴァスキュラー バイオジェニックス リミテッド Improved process for producing oxidized phospholipids
US7807847B2 (en) 2004-07-09 2010-10-05 Vascular Biogenics Ltd. Process for the preparation of oxidized phospholipids
US9006217B2 (en) 2007-01-09 2015-04-14 Vascular Biogenics Ltd. High-purity phospholipids
US8569529B2 (en) 2007-01-09 2013-10-29 Vascular Biogenics Ltd. High-purity phospholipids
NZ592357A (en) 2008-11-06 2013-09-27 Vascular Biogenics Ltd Oxidized lipid compounds and uses thereof
CA2968790A1 (en) 2014-11-26 2016-06-02 Vascular Biogenics Ltd. Oxidized lipids and treatment or prevention of fibrosis
US9771385B2 (en) 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
CN109789217A (en) * 2016-09-01 2019-05-21 凯文·乔恩·威廉姆斯 Methods and kits for reducing the sensitivity of lipoprotein particles to atherogenic aggregation by arterial wall enzymes
WO2020198063A1 (en) * 2019-03-27 2020-10-01 Kevin Jon Williams Administration of eicosapentaenoic acid and its derivatives to correct the susceptibility of apob-lipoproteins aggregation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3854940T2 (en) * 1987-05-20 1996-07-11 Rogosin Inst RECONSTRUCTED HDL PARTICLES AND THEIR USE
DE4018767A1 (en) * 1990-06-12 1991-12-19 Braun Melsungen Ag ACTIVE LIPOSOMES FOR THE TREATMENT OF ATHEROSCLEROSIS
DE4122744C2 (en) * 1990-08-06 1994-02-03 Nattermann A & Cie Aqueous liposome system and process for its preparation

Also Published As

Publication number Publication date
WO1995023592A1 (en) 1995-09-08

Similar Documents

Publication Publication Date Title
AU1751795A (en) Liposome compositions and methods for the treatment of atherosclerosis
AU4907897A (en) Therapeutic liposome composition and method
AU6079598A (en) Additive preparation and method of use thereof
AU2113295A (en) Novel compositions and methods for water treatment
AU4990397A (en) Compound-loaded liposomes and methods for their preparation
AU3091897A (en) Surf-or-sail-board and method of producing the same
AU3869895A (en) Azetidinone derivatives for the treatment of atherosclerosis
AU1532297A (en) Starch-emulsifier composition and methods of making
AU1803195A (en) Method of manufacutring fibreboard and fibreboard produced thereby
AU671577B3 (en) Compositions and methods for the control of smoking
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU2821295A (en) Compositions and methods for the treatment of tumors
AU1714697A (en) Method and composition for the treatment of osteoarthritis
AU3768795A (en) Method and compositions for hair treatment
AU3127795A (en) Composition and treatment for baldness
AU4505996A (en) 7-vinylidene cephalosporins and methods of using the same
AU1926597A (en) Treatment of cocoa
AU4027097A (en) Method of treatment
AU2966695A (en) Method and compound for the treatment of hair loss
AU4388899A (en) Novel compositions for the treatment of atherosclerosis and related conditions
AUPM836794A0 (en) Improved method and composition for the treatment of ulcers
AU3817899A (en) Therapy of atherosclerosis
AU1468797A (en) Ghrh-rp compositions and methods
AU3227295A (en) Oil treatment and compositions therefor
AU4217497A (en) Skap55 compositions and methods of use therefor